Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

Drug Manufacturers - Specialty & Generic

Healthcare
$4.78 +0.14%

+$0.01 today

Market cap
$791.33M
Beta
0.24
P/E (TTM)
5.6
EPS (TTM)
$0.63
52W Low $0.66High $5.78

Volume 2.22M

Average 2.35M

IRWD Total Non-current Assets

All assets not expected to be converted to cash within one year.

Ironwood Pharmaceuticals, Inc.NASDAQ: IRWD

Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Total non-current assets falls 38.6% from a year ago

Total non-current assets stood at $102.27M at the end of Q1 FY2026, down 38.6% from a year earlier and down 16.7% from the prior quarter. Over 3 fiscal years it compounded at -27.3% a year.

Context

  • Total non-current assets amounted to 23.5% of total assets at the end of Q1 FY2026, down 27.4 pp from a year earlier.
  • Total non-current assets increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total non-current assets keeps falling in the next quarterly balance sheet after a -38.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$102.27M-16.7% QoQ
Last fiscal yearDec 2025
$122.72M-27.2% YoY
Year agoMar 2025
$166.63M-38.6% since
Total Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-38.6%——
1 year-27.2%——
3-year CAGR-27.3%——
5-year CAGR——
10-year CAGR——

Total Non-current Assets history

USD · from the balance sheet

Latest · FY2025
122.72M USD
Year-over-year change
-27.2%
4-year CAGR
-24.7%

Total Non-current Assets vs competitors

How IRWD compares with its peers on the latest reported figures

  • IRWD's Mar 2026 total non-current assets of $102.27M is the 2nd highest of the 3 companies compared; the peer median is $61.32M.
  • Its year-over-year change of -38.6% is the lowest of 2, against a peer median of +25.8%.
  • Total non-current assets amounts to 23.5% of total assets for IRWD, versus a peer median of 12.2%.
IRWD Competitors Peer median
Total Non-current Assets for IRWD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ARDXArdelyx, Inc.Mar 2026$122.64M +25.8%+48.5%24.3%
IRWDIronwood Pharmaceuticals, Inc.Mar 2026$102.27M -38.6%-27.3%23.5%
SYRESpyre Therapeutics, Inc.Sep 2026$0 ——0.0%
Peer median (excluding IRWD) $61.32M+25.8%+48.5%12.2%

Competitors are the stored peer set for IRWD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents620.13M656.2M92.15M88.56M215.46M
Short-term Investments00000
Net Receivables114.04M115.46M129.12M81.89M46.75M
Inventory01.25M000
Other Current Assets2.37M0011.92M11.98M
Total Current Assets745.23M780.63M233.29M182.37M274.18M
Property, Plant & Equipment (Net)22.93M20.31M18.17M15.52M12.75M
Goodwill00000
Intangible Assets003.68M2.86M2.04M
Long-term Investments015.07M000
Tax Assets333.29M283.66M212.32M144.23M103.43M
Other Non-current Assets25.48M847K3.61M5.92M4.5M
Total Non-current Assets381.7M319.89M237.79M168.54M122.72M
Total Assets1.13B1.1B471.07M350.91M396.9M
Account Payables935K483K7.83M2.13M2.9M
Short-term Debt116.86M0199.56M0199.68M
Tax Payables0656K1.24M521K0
Deferred Revenue002.62M2.03M1.11M
Other Current Liabilities7.49M15.88M26.13M4.98M21M
Total Current Liabilities161.7M25.53M276.1M38.85M242.22M
Long-term Debt337.33M396.25M498.31M583.99M385M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities3.5M9.77M28.42M17.11M21.65M
Total Non-current Liabilities359.32M422.62M541.27M613.4M416.52M
Total Liabilities521.02M448.14M817.37M652.24M658.74M
Common Stock162K154K156K160K163K
Retained Earnings(937.61M)(696.38M)(1.7B)(1.7B)(1.67B)
Accumulated OCI(0)0(3.03M)923K(1.06M)
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity605.91M652.38M(346.3M)(301.34M)(261.83M)
Total Debt475.8M415.92M715.54M599.48M597.8M
Net Debt(144.33M)(240.29M)623.38M510.92M382.35M

Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

Intrinsic Alpha fair value

Locked

Current Price

$4.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.